Estrella Immunopharma, Inc. (ESLA)
0.39
-0.02
(-4.90%)
USD |
NASDAQ |
Nov 06, 10:08
Estrella Immunopharma Shareholders Equity (Quarterly) : -7.431M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.431M |
| March 31, 2026 | -5.270M |
| December 31, 2025 | -10.37M |
| September 30, 2025 | -9.836M |
| June 30, 2025 | -6.095M |
| March 31, 2025 | -1.831M |
| December 31, 2024 | 0.1437M |
| September 30, 2024 | 0.7463M |
| June 30, 2024 | 4.274M |
| March 31, 2024 | 8.495M |
| December 31, 2023 | 9.048M |
| Date | Value |
|---|---|
| September 30, 2023 | 10.07M |
| June 30, 2023 | 6.931M |
| March 31, 2023 | 7.007M |
| December 31, 2022 | 7.071M |
| September 30, 2022 | 43.33M |
| June 30, 2022 | 43.68M |
| March 31, 2022 | 44.04M |
| December 31, 2021 | 44.18M |
| September 30, 2021 | 44.32M |
| June 30, 2021 | 0.0206M |
| February 28, 2021 | 0.0242M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.825M |
| Total Liabilities (Quarterly) | 9.256M |
| Current Ratio | 0.1971 |